Henry Hinkle, MD
Gastroenterology · Monroe, LANPI 1730147786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 601 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations.
Across 601 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Olympus America Inc.$1K
- Johnson & Johnson$910
- Boston Scientific$726
- Bristol Myers Squibb$458
- plus $3K from 30 others
Across 176 payments — averaging $4173.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$374K
- GSK$205K
- Boehringer Ingelheim International GmbH$123K
- Janssen Research & Development, LLC$32K
What the payments were for
- Food & beverage$11,04899%
- Education$1541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,629 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 190 | $2,366 |
| Olympus America Inc. | 20 | $1,064 |
| Johnson & Johnson(2 entities) | 55 | $910 |
| Boston Scientific | 22 | $726 |
| Bristol Myers Squibb | 28 | $458 |
| Sanofi | 11 | $390 |
| Ardelyx, Inc. | 12 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $266 |
| Nestle Healthcare Nutrition Inc. | 9 | $229 |
| Pfizer | 14 | $220 |
| Phathom Pharmaceuticals, Inc. | 9 | $196 |
| Evoke Pharma, Inc. | 6 | $191 |
| Gilead | 10 | $144 |
| QOL Medical, LLC | 5 | $126 |
| Mauna Kea Technologies, Inc. | 7 | $112 |
| Braintree Laboratories, Inc. | 7 | $102 |
| Intercept Pharmaceuticals, Inc. | 7 | $93 |
| Lilly USA, LLC | 1 | $79 |
| Redhill Biopharma Inc. | 6 | $75 |
| Aimmune Therapeutics, Inc. | 4 | $63 |
| Merck | 4 | $57 |
| Cook Medical LLC | 3 | $53 |
| Novo Nordisk | 3 | $53 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Ferring Pharmaceuticals Inc. | 4 | $48 |
| Tersera Therapeutics LLC | 1 | $36 |
| Medtronic | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Shire North American Group Inc | 2 | $30 |
| Amgen | 1 | $16 |
| Ambu Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Celltrion USA Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,202 in reported general payments places this provider in the 80th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 20 | $157,570 |
| RinvoqUpadacitinib | 12 | $72,918 |
| CreonLipase/Protease/Amylase | 16 | $45,382 |
| LinzessLinaclotide | 32 | $17,229 |
| Sucralfate | 73 | $17,006 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 165 | $10,684 |
| Colestipol Hcl | 99 | $9,020 |
| Pantoprazole Sodium | 756 | $7,555 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 404 | $6,309 |
| MovantikNaloxegol Oxalate | 11 | $4,603 |
| Budesonide DrBudesonide | 29 | $3,561 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 195 | $2,992 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 13 | $2,067 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 11 | $1,784 |
| Mesalamine ErMesalamine | 14 | $1,530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Creon, Linzess | $2,629 | $135,52960 claims |
| Redhill Biopharma Inc.Movantik | $75 | $4,60311 claims |
| Braintree Laboratories, Inc.Sutab | $102 | $2,06713 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $48 | $1,78411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 254 gastroenterology providers in Louisiana.
Other gastroenterology in Monroe
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
- Gia LandryBaton Rouge$511K
- Charles MonierThibodaux$448K
- Nathaniel RanneyCovington$392K
- Georges CatinisMetairie$346K
- Humberto AguilarShreveport$313K
- Sarah GloverNew Orleans$274K
- Nisha LoganantharajNew Orleans$173K
- Shamita ShahNew Orleans$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.